Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Granulocytic Myeloid-Derived Suppressor Cells as Negative Regulators of Anticancer Immunity

Frontiers in Immunology(2020)10.3389/fimmu.2020.01963Source: DataRank Database

Granulocytic Myeloid-Derived Suppressor Cells as Negative Regulators of Anticancer Immunity is a research paper published in Frontiers in Immunology (2020). On theSindex it has a DataRank of 0. It has been cited 53 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access53 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: goldTopics (32)IDs (PubMed, PMC)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Scott I. Abrams,Elliot D. Kramer ORCID

Live enrichment

PubMed:32983128 PMC:PMC7481329

National Institutes of Health

Grant: R01CA172105

National Institutes of Health

Grant: T32CA085183

NCI NIH HHS

Grant: F30 CA254327

National Institutes of Health

Grant: 1R01CA172105-01A1

Mechanisms Underlying Functional Programs of Tumor-Associated Macrophages

National Institutes of Health

Grant: 5T32CA085183-13

Multidisciplinary Approaches to Tumor Immunology

goldLicense: cc-by

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2020.01963/pdf

publisherhttps://www.frontiersin.org/article/10.3389/fimmu.2020.01963/full

repositoryhttps://doaj.org/article/5054f3a422d748ee98872ef5a242b9ce

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7481329

Europe_PMChttps://europepmc.org/articles/PMC7481329

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

AnimalsHumansNeoplasmsAntineoplastic AgentsImmunotherapySignal TransductionTumor EscapePhenotypeMolecular Targeted TherapyTumor MicroenvironmentMyeloid-Derived Suppressor Cells

Keywords

ImmunotherapyAntitumor immunityimmune suppressionTumor ProgressionPolymorphonuclear Myeloid-derived Suppressor CellsMyeloid-Derived Suppressor CellsImmunologyAntineoplastic AgentsRC581-607PhenotypeNeoplasmsTumor MicroenvironmentAnimalsHumansTumor EscapeMolecular Targeted TherapyImmunologic diseases. AllergySignal Transduction

Sustainable Development Goals

SDG 3: 3. Good health

Granulocytic Myeloid-Derived Suppressor Cells as Negative Regulators of Anticancer Immunity

FAIR Checklist

Authors (2)

Funding (5 grants)

Open Access

Topics

Annotations (Europe PMC)